Docivyx
NDC Package 83831-129-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Docivyx is a . Marketed by Avyxa Pharma, Llc, this product is identified by NDC 83831-129 and is authorized under FDA application NDA215813.

Identification & Billing

NDC Package Code
83831-129-08
Package Description
1 VIAL, GLASS in 1 CARTON / 8 mL in 1 VIAL, GLASS
Product Code
83831-129
11-Digit Billing Format
83831012908

Clinical Specifications

Proprietary Name
Docivyx
Dosage Form
-

Regulatory & Marketing

Labeler Name
Avyxa Pharma, Llc
FDA Application #
NDA215813
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-17-2025
End Marketing Date
01-17-2025
Listing Expiration
01-17-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83831-129-08 identifies a specific commercial package of 1 vial, glass in 1 carton / 8 ml in 1 vial, glass of Docivyx, labeled by Avyxa Pharma, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Avyxa Pharma, Llc on January 17, 2025. The current certification is valid through January 17, 2025.

How is this Avyxa Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83831012908. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83831-129-08
11-Digit CMS (5-4-2)
83831-0129-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.